PCV89 COST EFFECTIVENESS OF PRASAGREL OR CHOPIDOGREL FOR TREATMENT OF ACS PATIENTS BASED ON GENETIC TESTING FOR CYP2C19 VARIANTS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72808-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)72808-4/fulltext
Title :
PCV89 COST EFFECTIVENESS OF PRASAGREL OR CHOPIDOGREL FOR TREATMENT OF ACS PATIENTS BASED ON GENETIC TESTING FOR CYP2C19 VARIANTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72808-4&doi=10.1016/S1098-3015(10)72808-4
First page :
Section Title :
Open access? :
No
Section Order :
368